Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 5Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Neoplasm Metastasis 1Locally Advanced/ Metastatic NSCLC 1HER2-positive Advanced Breast Cancer 1Breast Cancer Organoids 1Brain Neoplasms 1Advanced Breast Cancer 1

Interventions

atezolizumab 5durvalumab 4Drug Therapy 4Carboplatin 4Psychiatric Rehabilitation 3Immunotherapy 3Topotecan 2Specimen Handling 2Radiotherapy 2Polymerase Chain Reaction 2PM 01183 2Observation 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Ifosfamide 2Etoposide 2Cisplatin 2Biopsy 2trastuzumab deruxtecan 1nedaplatin 1X-Ray Therapy 1Watchful Waiting 1Vinorelbine 1Tomography, Optical Coherence 1Tissue Banks 1Therapeutics 1Radiation, Ionizing 1Phlebotomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Small Cell Lung Carcinoma × Vinorelbine × Clear all
NCT01752517 2012-12-19

Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer

Peking Union Medical College Hospital

Unknown
60 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡